• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种内源性鼠逆转录病毒的包膜蛋白是多种鼠肿瘤的肿瘤相关T细胞抗原。

The envelope protein of an endogenous murine retrovirus is a tumor-associated T-cell antigen for multiple murine tumors.

作者信息

Yang J C, Perry-Lalley D

机构信息

Surgery Branch, National Cancer Institute, Bethesda, Maryland, USA.

出版信息

J Immunother. 2000 Mar-Apr;23(2):177-83. doi: 10.1097/00002371-200003000-00001.

DOI:10.1097/00002371-200003000-00001
PMID:10746543
Abstract

Recently, significant progress has been made in identifying specific tumor-associated antigens recognized by T cells and defining the specific peptide epitopes within these proteins that are processed and presented on class I major histocompatibility antigens. Most of these antigens have been identified in human melanoma, where many of them appear to be tissue-specific, nonmutated proteins expressed by melanoma and normal melanocytes but not by other tissues. There has been much less progress in identifying the tumor antigens on murine tumors that are recognized by T cells, and this has restricted the development of preclinical animal models for immunotherapy. The authors previously described a method for generating tumor-reactive T cells from murine tumors (tumor infiltrating lymphocytes) that are CD8+ T cells recognizing autologous tumor and that can inhibit established tumor on adoptive transfer. Here the authors show that the envelope protein of an endogenous murine retrovirus of the AKV family, found in the germline of the C57BL/6 mouse, is recognized by tumor-infiltrating lymphocytes from two histologically different tumors syngeneic to that mouse strain. Furthermore, the authors identify the specific 9-amino acid peptide from the p15E transmembrane component of this envelope protein that is recognized in the context of major histocompatibility complex Kb, show that it is naturally presented and recognized on several other H-2b tumors, and that cytotoxic T lymphocytes specific for this epitope are therapeutic for these antigen-expressing tumors on adoptive transfer.

摘要

最近,在识别T细胞识别的特定肿瘤相关抗原以及确定这些蛋白质中经加工后呈递于I类主要组织相容性抗原上的特定肽表位方面取得了重大进展。这些抗原大多是在人类黑色素瘤中发现的,其中许多似乎是黑色素瘤和正常黑素细胞表达的组织特异性、未突变的蛋白质,而其他组织不表达。在识别小鼠肿瘤上被T细胞识别的肿瘤抗原方面进展要少得多,这限制了免疫治疗临床前动物模型的发展。作者之前描述了一种从鼠肿瘤(肿瘤浸润淋巴细胞)中产生肿瘤反应性T细胞的方法,这些细胞是识别自体肿瘤的CD8 + T细胞,在过继转移时可抑制已形成的肿瘤。在此,作者表明,在C57BL / 6小鼠种系中发现的AKV家族内源性鼠逆转录病毒的包膜蛋白,被来自与该小鼠品系同基因的两种组织学不同肿瘤的肿瘤浸润淋巴细胞识别。此外,作者从该包膜蛋白的p15E跨膜成分中鉴定出特定的9个氨基酸肽,该肽在主要组织相容性复合体Kb的背景下被识别,表明它在其他几种H-2b肿瘤上自然呈递并被识别,并且针对该表位的细胞毒性T淋巴细胞在过继转移时对这些表达抗原的肿瘤具有治疗作用。

相似文献

1
The envelope protein of an endogenous murine retrovirus is a tumor-associated T-cell antigen for multiple murine tumors.一种内源性鼠逆转录病毒的包膜蛋白是多种鼠肿瘤的肿瘤相关T细胞抗原。
J Immunother. 2000 Mar-Apr;23(2):177-83. doi: 10.1097/00002371-200003000-00001.
2
Multiple HLA class II-restricted melanocyte differentiation antigens are recognized by tumor-infiltrating lymphocytes from a patient with melanoma.多种HLA II类限制性黑素细胞分化抗原可被一名黑色素瘤患者的肿瘤浸润淋巴细胞识别。
J Immunol. 2002 Nov 15;169(10):6036-47. doi: 10.4049/jimmunol.169.10.6036.
3
Effective genetic vaccination with a widely shared endogenous retroviral tumor antigen requires CD40 stimulation during tumor rejection phase.使用广泛共享的内源性逆转录病毒肿瘤抗原进行有效的基因疫苗接种需要在肿瘤排斥阶段进行CD40刺激。
J Immunol. 2003 Dec 15;171(12):6396-405. doi: 10.4049/jimmunol.171.12.6396.
4
The cytotoxic T-lymphocyte response against a poorly immunogenic mammary adenocarcinoma is focused on a single immunodominant class I epitope derived from the gp70 Env product of an endogenous retrovirus.针对免疫原性较差的乳腺腺癌的细胞毒性T淋巴细胞反应集中于源自内源性逆转录病毒的gp70 Env产物的单个免疫显性I类表位。
Cancer Res. 2003 May 1;63(9):2158-63.
5
Tumor-infiltrating lymphocytes exhibiting high ex vivo cytolytic activity fail to prevent murine melanoma tumor growth in vivo.具有高离体细胞溶解活性的肿瘤浸润淋巴细胞无法在体内阻止小鼠黑色素瘤肿瘤的生长。
J Immunol. 1998 Sep 1;161(5):2187-94.
6
Distinct proliferative T cell clonotypes are generated in response to a murine retrovirus-induced syngeneic T cell leukemia: viral gp70 antigen-specific MT4+ clones and Lyt-2+ cytolytic clones which recognize a tumor-specific cell surface antigen.针对小鼠逆转录病毒诱导的同基因T细胞白血病,会产生不同的增殖性T细胞克隆型:病毒gp70抗原特异性MT4 +克隆和识别肿瘤特异性细胞表面抗原的Lyt-2 +溶细胞克隆。
J Immunol. 1985 Jul;135(1):703-13.
7
Isolation of a new melanoma antigen, MART-2, containing a mutated epitope recognized by autologous tumor-infiltrating T lymphocytes.一种新的黑色素瘤抗原MART-2的分离,该抗原含有一个被自体肿瘤浸润性T淋巴细胞识别的突变表位。
J Immunol. 2001 Feb 15;166(4):2871-7. doi: 10.4049/jimmunol.166.4.2871.
8
The immunodominant major histocompatibility complex class I-restricted antigen of a murine colon tumor derives from an endogenous retroviral gene product.一种小鼠结肠肿瘤的免疫显性主要组织相容性复合体I类限制性抗原源自一种内源性逆转录病毒基因产物。
Proc Natl Acad Sci U S A. 1996 Sep 3;93(18):9730-5. doi: 10.1073/pnas.93.18.9730.
9
Specific T helper cell requirement for optimal induction of cytotoxic T lymphocytes against major histocompatibility complex class II negative tumors.针对主要组织相容性复合体II类阴性肿瘤诱导细胞毒性T淋巴细胞的最佳诱导对特定辅助性T细胞的需求。
J Exp Med. 1998 Mar 2;187(5):693-702. doi: 10.1084/jem.187.5.693.
10
Cytotoxic T lymphocytes to endogenous mouse retroviruses and mechanisms of retroviral escape.
Immunol Rev. 1999 Apr;168:271-86. doi: 10.1111/j.1600-065x.1999.tb01298.x.

引用本文的文献

1
Rewiring endogenous genes in CAR T cells for tumour-restricted payload delivery.在嵌合抗原受体(CAR)T细胞中重编程内源基因以实现肿瘤特异性的有效载荷递送
Nature. 2025 Jul 2. doi: 10.1038/s41586-025-09212-7.
2
Endogenous viral elements constitute a complementary source of antigens for personalized cancer vaccines.内源性病毒元件构成了个性化癌症疫苗抗原的补充来源。
NPJ Vaccines. 2025 Mar 20;10(1):54. doi: 10.1038/s41541-025-01107-y.
3
Inhibition of Glutamate-to-Glutathione Flux Promotes Tumor Antigen Presentation in Colorectal Cancer Cells.
抑制谷氨酸到谷胱甘肽的通量可促进结肠癌细胞中的肿瘤抗原呈递。
Adv Sci (Weinh). 2025 Jan;12(1):e2310308. doi: 10.1002/advs.202310308. Epub 2024 Oct 31.
4
Exploring HERV-K (HML-2) Influence in Cancer and Prospects for Therapeutic Interventions.探讨 HERV-K(HML-2)在癌症中的影响及治疗干预的前景。
Int J Mol Sci. 2023 Sep 27;24(19):14631. doi: 10.3390/ijms241914631.
5
OncoVEXexpands tumor antigen-specific CD8+ T-cell response in preclinical models.OncoVEX 可增强临床前模型中肿瘤抗原特异性 CD8+ T 细胞应答。
J Immunother Cancer. 2023 May;11(5). doi: 10.1136/jitc-2022-006374.
6
Late-stage MC38 tumours recapitulate features of human colorectal cancer - implications for appropriate timepoint selection in preclinical studies.晚期 MC38 肿瘤重现人类结直肠癌的特征 - 对临床前研究中适当时间点选择的影响。
Front Immunol. 2023 Apr 21;14:1152035. doi: 10.3389/fimmu.2023.1152035. eCollection 2023.
7
An Endogenous Retrovirus Vaccine Encoding an Envelope with a Mutated Immunosuppressive Domain in Combination with Anti-PD1 Treatment Eradicates Established Tumours in Mice.一种内源性逆转录病毒疫苗,其包膜编码一个具有突变免疫抑制结构域的包膜,与抗 PD-1 治疗联合使用,可根除小鼠体内的已建立肿瘤。
Viruses. 2023 Apr 6;15(4):926. doi: 10.3390/v15040926.
8
An Immunogenic Model of KRAS-Mutant Lung Cancer Enables Evaluation of Targeted Therapy and Immunotherapy Combinations.KRAS 突变型肺癌的免疫原性模型可用于评估靶向治疗和免疫治疗的联合应用。
Cancer Res. 2022 Oct 4;82(19):3435-3448. doi: 10.1158/0008-5472.CAN-22-0325.
9
Identification of Highly Cross-Reactive Mimotopes for a Public T Cell Response in Murine Melanoma.鉴定鼠黑色素瘤中公共 T 细胞反应的高交叉反应模拟表位。
Front Immunol. 2022 Jun 23;13:886683. doi: 10.3389/fimmu.2022.886683. eCollection 2022.
10
NHS-IL12, a Tumor-Targeting Immunocytokine.NHS-IL12,一种肿瘤靶向免疫细胞因子。
Immunotargets Ther. 2021 May 27;10:155-169. doi: 10.2147/ITT.S306150. eCollection 2021.